Jci_page_head_homepage_01 Jci_page_head_homepage_02
Beata U. Gajewska, David Alvarez, Mariana Vidric, Susanna Goncharova, Martin R. Stämpfli, Anthony J. Coyle, José-Carlos Gutierrez-Ramos, Manel Jordana
Published in Volume 108, Issue 4
J Clin Invest. 2001; 108(4):577–583 doi:10.1172/JCI12627
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 5

In vivo rechallenge of C57BL/6 (WT) and LT-α–deficient (LTα-KO) mice exposed to OVA in the context of GM-CSF. At day 60, after complete resolution of the airway inflammation, mice were re-exposed to aerosolized OVA for 3 consecutive days. Data show total cell number and differential of cells obtained 72 hours after last challenge from BAL (mean ± SEM; n = 4–6; statistical analysis was performed using Student’s t test; *P < 0.05).